Skip to content

The fate of incomplete amino acid metabolism in type 2 diabetes

The fate of incomplete amino acid metabolism in type 2 diabetes - amino acids in type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43574
Enrollment
30
Registered
2013-12-04
Start date
2014-02-21
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus type 2 sugar disease

Interventions

A randomized, cross-over study in which patients with T2DM and first degree relatives will undergo a 4 week dietary intervention with normal BCAA in the diet or to a 4 week intervention with low BCA

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Overall * Male en postmenopausal females * Age 45-70 years * Body mass index (BMI) 27 kg/m2 * Stable dietary habits (no weight loss/gain >5 kg in the last 3 months) * Stable physical activity levels for at least 6 months * Control participants without type 2 diabetes should be normal glucose tolerant (OGTT with fasting plasma glucose

Exclusion criteria

Exclusion criteria: - participants will be excluded when being diagnosed with active cardiovascular disease, diabetic foot, polyneuropathy, retinopathy - participants will be excluded when having uncontrolled hypertension - participants following a vegetarian diet or having an allergy against soya - participants with contra-indication for MRI

Design outcomes

Primary

MeasureTime frame
The primary study objectives are: i) to determine whether T2DM and FDR have lower rate of leucine oxidation (umol kg-1 min-1) in muscle ii) to evaluate whether altered leucine oxidation is associated with whole body and hepatic insulin sensitivity (umol kg-1 min-1)

Secondary

MeasureTime frame
The secondary study objectives are: i) to evaluate whether altered leucine oxidation is associated with mitochondrial function (pmol/mg/s) ii) to evaluate whether altered leucine oxidation is associated with the amount of liver fat (%)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)